{"database": "openregs", "table": "documents", "rows": [["EPA-HQ-OGC-2024-0391-0001", "EPA", "EPA-HQ-OGC-2024-0391", "Proposed Partial Settlement Agreement and Consent Decree, Claim Regarding Implementation of Endocrine Disruptor Screening Program Under the Section 408(p) of the Federal Food, Drug, and Cosmetic Act (FFDCA)", "Notice", "Consent Decree", "2024-10-11T04:00:00Z", 2024, 10, "2024-10-11T04:00:00Z", "2024-11-13T04:59:59Z", "2024-11-13T02:01:18Z", "2024-23633", 0, 0, "09000064867c96f3"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["EPA-HQ-OGC-2024-0391-0001"], "units": {}, "query_ms": 0.4720309516415, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}